Comorbidity Burden and Social Determinants of Health Among U.S. Hospitalizations for Multiple Sclerosis: A National Inpatient Sample Analysis
Neuroepidemiology · 09.11.2026
DOI: 10.1159/ned/adwag066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroepidemiology, online erschienen am 09.11.2026. Verfasst von Aneesh Kamath und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Individuals hospitalized with Multiple Sclerosis (MS) often experience comorbid conditions that affect their quality of life and also face social determinants of health (SDOH) that affect outcomes.
Methods
Data were leveraged from the 2019 National Inpatient Sample database, a component of the Nationwide Healthcare Cost and Utilization Project, a government survey of hospitalizations across the US, and theoretically representative of all hospitalizations in the US. We compared patients hospitalized with MS to patients hospitalized without MS across demographic characteristics and common concomitant diagnoses. In a secondary analysis restricted to MS hospitalizations, we examined the association of comorbidities and SDOH with length of stay.
Results
Between January 2019 and December 2019 there were a total of 25,155 hospitalizations for MS and 35,392,578 hospitalizations without MS. Mean age at admission was 45.9 years for MS versus 50.2 years for non-MS hospitalizations (p < 0.001). Patients hospitalized with MS were more likely to be female and more diverse than non-MS hospitalizations. Patients with MS were more likely to have a diagnosis of anxiety (18.9% versus 10.2%, p < 0.001), chronic pain (10.5% versus 5%, p < 0.001), and depression (21.8% versus 9.9%, p < 0.001) compared to non-MS hospitalizations. Among MS hospitalizations, depression diagnoses were reported less often among Black vs. non-Black (16.6% versus 23.6%, p < 0.001), Hispanic vs. Non-Hispanic (13.8% versus 22.7%, p < 0.001), and patients on Medicaid vs. non-Medicaid (19.1% versus 22.6%, p < 0.001). In a regression model restricted to MS patients, number of comorbidities and Black compared to non-Black race corresponded to increasing length of stay.
Conclusion
MS patients have higher rates of anxiety, depression, and pain compared to non-MS patients. Minoritized groups with MS are less likely to be given a secondary diagnosis code for depression, anxiety or pain, possibly reflecting underdiagnosis of these conditions.
Autor:innen und Institutionen
ORCID-Profile: Mihir Kakara, Cheryl R Stein, Kimberly A O'Neill
Zitieren
APA
Kamath, A., Kakara, M., Stein, C. R., Shi, Y., Krupp, L., & O'Neill, K. A. (2026). Comorbidity Burden and Social Determinants of Health Among U.S. Hospitalizations for Multiple Sclerosis: A National Inpatient Sample Analysis. Neuroepidemiology. https://doi.org/10.1159/ned/adwag066
Vancouver
Kamath A, Kakara M, Stein CR, Shi Y, Krupp L, O'Neill KA. Comorbidity Burden and Social Determinants of Health Among U.S. Hospitalizations for Multiple Sclerosis: A National Inpatient Sample Analysis. Neuroepidemiology. 2026. doi:10.1159/ned/adwag066
BibTeX
@article{Kamath2026,
author = {Kamath, Aneesh and Kakara, Mihir and Stein, Cheryl R and Shi, Yidan and Krupp, Lauren and O'Neill, Kimberly A},
title = {Comorbidity Burden and Social Determinants of Health Among U.S. Hospitalizations for Multiple Sclerosis: A National Inpatient Sample Analysis},
journal = {Neuroepidemiology},
year = {2026},
doi = {10.1159/ned/adwag066}
}
EUVIMED